Identification and validation of biomarkers associated with acute and chronic graft versus host disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification and validation of biomarkers associated with acute and chronic graft versus host disease
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 50, Issue 12, Pages 1563-1571
Publisher
Springer Nature
Online
2015-09-14
DOI
10.1038/bmt.2015.191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
- (2015) Margaret L. MacMillan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
- (2015) D. K. Reichenbach et al. BLOOD
- A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
- (2015) John E Levine et al. Lancet Haematology
- High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
- (2014) Doris M. Ponce et al. BLOOD
- Plasma biomarkers of lower gastrointestinal and liver acute GVHD
- (2012) A. C. Harris et al. BLOOD
- Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
- (2012) J. E. Levine et al. BLOOD
- Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD
- (2012) J. E. Croudace et al. BLOOD
- Diagnosis and management of acute graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Inflammasome Activation of IL-1 Family Mediators in Response to Cutaneous Photodamage†
- (2012) Tahseen H. Nasti et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Regulatory T Cells Inhibit CD8+ T-Cell Tissue Invasion in Human Skin Graft-Versus-Host Reactions
- (2012) Emily Mavin et al. TRANSPLANTATION
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis
- (2011) M. Arora et al. BLOOD
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
- (2011) M. E. D. Flowers et al. BLOOD
- Danger signals activating innate immunity in graft-versus-host disease
- (2011) Robert Zeiser et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease
- (2009) K. Landfried et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis
- (2009) W. N. Khan JOURNAL OF IMMUNOLOGY
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
- (2009) C. Cayrol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolongation of Cardiac and Islet Allograft Survival by a Blocking Hamster Anti-Mouse CXCR3 Monoclonal Antibody
- (2009) Ravindra Uppaluri et al. TRANSPLANTATION
- A biomarker panel for acute graft-versus-host disease
- (2008) S. Paczesny et al. BLOOD
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Intestinal Ischemia/Reperfusion Injury Triggers Activation of Innate Toll-Like Receptor 4 and Adaptive Chemokine Programs
- (2008) M.J. Watson et al. TRANSPLANTATION PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More